Standout Papers

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma 2022 2026 2023 2024134
  1. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma (2022)
    Christopher L. Bowlus, Lionel Arrivé et al. Hepatology

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 61 standout
Sub-graph 1 of 21

Citing Papers

Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
1 intermediate paper

Works of Keri E. Lunsford being referenced

Predicting Mortality in Patients Developing Recurrent Hepatocellular Carcinoma After Liver Transplantation
2016

Author Peers

Author Last Decade Papers Cites
Keri E. Lunsford 658 458 161 220 48 1.0k
M. Golling 550 471 81 231 86 1.1k
Horng-Ren Yang 496 323 262 127 44 1.0k
Ting-Jung Wu 547 636 66 222 72 992
Steffen Manekeller 568 459 126 149 80 1.0k
H.‐J. Gassel 503 480 90 280 69 910
Giuliano La Barba 649 874 45 197 36 1.2k
Joseph DiNorcia 578 323 57 434 51 947
Harvey Solomon 620 719 58 189 63 1.4k
Hong‐Shiue Chou 502 712 63 204 85 1.1k
Justin Parekh 411 337 63 170 35 931

All Works

Loading papers...

Rankless by CCL
2026